|
Gene: CFAP43 |
Gene summary for CFAP43 |
Gene summary. |
Gene information | Species | Human | Gene symbol | CFAP43 | Gene ID | 80217 |
Gene name | cilia and flagella associated protein 43 | |
Gene Alias | C10orf79 | |
Cytomap | 10q25.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q8NDM7 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
80217 | CFAP43 | RNA-P6T1-P6T1-1 | Human | Lung | MIAC | 3.00e-03 | 7.11e-01 | -0.0238 |
80217 | CFAP43 | RNA-P6T1-P6T1-2 | Human | Lung | MIAC | 4.12e-03 | 6.71e-01 | -0.0186 |
80217 | CFAP43 | RNA-P6T1-P6T1-4 | Human | Lung | MIAC | 2.24e-04 | 6.83e-01 | -0.0263 |
80217 | CFAP43 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 3.12e-03 | 1.78e-01 | -0.0132 |
80217 | CFAP43 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 3.91e-04 | 1.97e-01 | -0.013 |
Page: 1 |
Transcriptomic changes along malignancy continuum. |
Tissue | Expression Dynamics | Abbreviation |
Lung | AAH: Atypical adenomatous hyperplasia | |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0007585 | Lung | IAC | respiratory gaseous exchange by respiratory system | 18/2061 | 68/18723 | 2.99e-04 | 4.82e-03 | 18 |
GO:0099111 | Lung | IAC | microtubule-based transport | 35/2061 | 190/18723 | 1.55e-03 | 1.64e-02 | 35 |
GO:0060271 | Lung | IAC | cilium assembly | 55/2061 | 337/18723 | 1.84e-03 | 1.88e-02 | 55 |
GO:0044782 | Lung | IAC | cilium organization | 58/2061 | 368/18723 | 3.15e-03 | 2.75e-02 | 58 |
GO:00602711 | Lung | MIAC | cilium assembly | 37/967 | 337/18723 | 1.29e-05 | 9.85e-04 | 37 |
GO:00447821 | Lung | MIAC | cilium organization | 38/967 | 368/18723 | 3.93e-05 | 2.08e-03 | 38 |
GO:00075853 | Lung | MIAC | respiratory gaseous exchange by respiratory system | 11/967 | 68/18723 | 6.76e-04 | 1.59e-02 | 11 |
GO:00328861 | Lung | MIAC | regulation of microtubule-based process | 23/967 | 240/18723 | 3.27e-03 | 4.31e-02 | 23 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CFAP43 | SNV | Missense_Mutation | c.2559N>A | p.His853Gln | p.H853Q | Q8NDM7 | protein_coding | tolerated(1) | benign(0) | TCGA-33-4533-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CFAP43 | SNV | Missense_Mutation | c.694N>T | p.Ala232Ser | p.A232S | Q8NDM7 | protein_coding | tolerated(0.07) | possibly_damaging(0.717) | TCGA-33-4566-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
CFAP43 | SNV | Missense_Mutation | c.4534G>C | p.Glu1512Gln | p.E1512Q | Q8NDM7 | protein_coding | tolerated(0.08) | probably_damaging(0.957) | TCGA-33-4583-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
CFAP43 | SNV | Missense_Mutation | c.3920N>G | p.Tyr1307Cys | p.Y1307C | Q8NDM7 | protein_coding | deleterious(0) | probably_damaging(0.983) | TCGA-39-5021-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | etoposide | PD | |
CFAP43 | SNV | Missense_Mutation | c.3469G>A | p.Glu1157Lys | p.E1157K | Q8NDM7 | protein_coding | deleterious(0) | probably_damaging(0.99) | TCGA-52-7809-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
CFAP43 | SNV | Missense_Mutation | c.3800N>C | p.Arg1267Thr | p.R1267T | Q8NDM7 | protein_coding | deleterious(0) | benign(0.366) | TCGA-66-2778-01 | Lung | lung squamous cell carcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR | |
CFAP43 | SNV | Missense_Mutation | rs761809673 | c.1505N>G | p.Asn502Ser | p.N502S | Q8NDM7 | protein_coding | tolerated(0.18) | benign(0.003) | TCGA-85-8288-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
CFAP43 | SNV | Missense_Mutation | novel | c.4246N>C | p.Glu1416Gln | p.E1416Q | Q8NDM7 | protein_coding | deleterious(0.01) | possibly_damaging(0.793) | TCGA-85-A513-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CFAP43 | SNV | Missense_Mutation | novel | c.3844N>A | p.Ala1282Thr | p.A1282T | Q8NDM7 | protein_coding | deleterious(0.04) | possibly_damaging(0.793) | TCGA-85-A53L-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CFAP43 | SNV | Missense_Mutation | novel | c.513N>G | p.Cys171Trp | p.C171W | Q8NDM7 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-O2-A52N-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |